These findings showed that Bcl-xL deficiency markedly inhibited the proliferation and migration of MDCK cells in vitro, indicating Bcl-xL could play a role in reducing tumor formation capacity in MDCK cells in vivo. The gene discussed is BCL2L1; the disease is neoplasm.